pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LEADING · news · pharmadog
← back to LEADING
News mentioning LEADING
653
stories
Jul 10, 26
STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
stat
Jul 10, 26
New York boys club has a time-tested recipe to protect members’ mental health
stat
Jul 9, 26
GSK ends brain drug alliance with Alector
biopharma dive
Jul 9, 26
STAT+: FDA finalists under review
stat
Jul 9, 26
Eli Lilly dominates first-half biotech acquisitions, with no sign of slowing down
endpoints
Jul 9, 26
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
Jul 9, 26
Who’s going to run the FDA?
stat
Jul 9, 26
Opinion: Your grandparents are using cannabis. Doctors can help them do it safely
stat
Jul 9, 26
Opinion: Who benefits from classifying obesity as a disease?
stat
Jul 8, 26
Bryan Johnson’s chronic disease is notoriously difficult to diagnose
stat
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 8, 26
Opinion: The AI licensure debate is missing the point of licensure
stat
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
Jul 7, 26
Infusion Pump Correction: Fresenius Kabi Issues Correction for dropped or jarred Ivenix Large Volume Infusion Pumps
fda medwatch
Jul 6, 26
Novartis to acquire ADC developer in a deal worth up to $1.5B
biopharma dive
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
stat
Jul 2, 26
STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
stat
Jul 2, 26
The new presidential fitness test is a positive step, not the solution, experts say
stat
Jul 2, 26
Heart Pump Recall: Abiomed Removes Impella CP Sets with SmartAssist
fda medwatch
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
Jun 30, 26
These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.
biopharma dive
Jun 30, 26
Opinion: Florida is the first state to require EKGs for high school athletes. It’s a mistake
stat
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 20, 26
Opinion: STAT readers debate blue zones, open-access publishing fees, and more
stat
← prev
page 17 of 22
next →
